2021 annual financial data
AN2 Therapeutics 2021 Operating cash flow margin
Direct answer
Operating cash flow margin was Not calculable.
Operating income was -21,574,000 USD and net income was -21,474,000 USD.
Operating cash flow was -20,484,000 USD.
Get free AN2 Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -21,574,000 USD
- Net income
- -21,474,000 USD
- Operating cash flow
- -20,484,000 USD